International Society of Geriatric Oncology (SIOG) shared a post on LinkedIn:
“New in JGO
Survival benefit from evidence-based treatment for rectal cancer among older people – Analysis of SEER-Medicare
How often do older adults with stage III Rectal Cancer receive guideline-based care? And does it change survival?
In this large SEER-Medicare analysis of nearly 4,000 patients, only 25% received all recommended multimodal treatments. Receipt of guideline-based care was associated with significantly improved overall and cancer-specific survival.
Age, comorbidities, income, and geography were linked to lower adherence.
These findings highlight persistent gaps in delivering evidence-based care to older adults.
SIOG members enjoy free online access to JGO.”
Title: Survival benefit from evidence-based treatment for rectal cancer among older people – Analysis of SEER-medicare
Authors: Uma R. Phataka, Yong Shand, Yong-Fang Kuo
Read the Full Article.
Other articles from SIOG.
